Concepedia

Achim K. Moesta

AK

Statistics

Publications

16

Citations

1.9K

H-Index

15

Active since

2002

Affiliations

Stanford University(Current)

Amgen (United States)

QIMR Berghofer Medical Research Institute

Stanford Medicine

Instituto Venezolano de Investigaciones Científicas

Achim K. Moesta is an author at Stanford University specializing in medicine, immunology, and autoimmunity.

ORCID

Top concepts

Publications per year

2002–2020

16

Publications

16

Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3

Achim K. Moesta, Paul J. Norman, Makoto Yawata et al. · The Journal of Immunology · 2008 · 383 citations · Full text

Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity

Xian-Yang Li, Achim K. Moesta, Christos Xiao et al. · Cancer Discovery · 2019 · 256 citations · Full text

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C

Thorsten Graef, Achim K. Moesta, Paul J. Norman et al. · The Journal of Experimental Medicine · 2009 · 232 citations · Full text

Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes

Paul J. Norman, Laurent Abi‐Rached, Ketevan Gendzekhadze et al. · Genome Research · 2009 · 124 citations · Full text

, , +15

Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands

Ketevan Gendzekhadze, Paul J. Norman, Laurent Abi-Rached et al. · Proceedings of the National Academy of Sciences · 2009 · 116 citations · Full text

, , +14

1–5 of 16